Soluble urokinase plasminogen activator receptor (suPAR) is a circulating biomarker of inflammation. A recent study identifies immature myeloid cells in the bone marrow as a major cellular source of suPAR that contributes to kidney disease.
This is a preview of subscription content, access via your institution
Relevant articles
Open Access articles citing this article.
-
suPAR as a marker of infection in acute kidney injury – a prospective observational study
BMC Nephrology Open Access 02 August 2018
Access options
Access Nature and 54 other Nature Portfolio journals
Get Nature+, our best-value online-access subscription
$29.99 / 30 days
cancel any time
Subscribe to this journal
Receive 12 print issues and online access
$209.00 per year
only $17.42 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
References
Wei, C. et al. Nat. Med. 14, 55–63 (2008).
Wei, C. et al. Nat. Med. 17, 952–960 (2011).
Spinale, J.M. et al. Kidney Int. 87, 564–574 (2015).
Eugen-Olsen, J. et al. J. Intern. Med. 268, 296–308 (2010).
Hayek, S.S. et al. N. Engl. J. Med. 373, 1916–1925 (2015).
Hahm, E. Nat. Med. 23, 100–106 (2017).
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Competing interests
The authors declare no competing financial interests.
Rights and permissions
About this article
Cite this article
Shankland, S., Jefferson, J. A bone marrow factor contributes to kidney disease. Nat Med 23, 13–14 (2017). https://doi.org/10.1038/nm.4263
Published:
Issue Date:
DOI: https://doi.org/10.1038/nm.4263
This article is cited by
-
suPAR as a marker of infection in acute kidney injury – a prospective observational study
BMC Nephrology (2018)
-
The gut microbiota and the brain–gut–kidney axis in hypertension and chronic kidney disease
Nature Reviews Nephrology (2018)